Symbols

CNO

CNO Financial Group·NYSE

--(--)

CNO fundamentals

CNO Q4 2025 Earnings

CNO Financial Group (CNO) released its earnings on Feb 5, 2026: revenue was 1.14B (YoY +3.90%), beat estimates; EPS was 1.47 (YoY +12.21%), beat estimates.

Revenue / YoY

1.14B

+3.90%

EPS / YoY

1.47

+12.21%

Report date

Feb 5, 2026

CNO Earnings Call Summary for Q4,2025

Record Growth and Profitability: 15% NAP growth, 11.4% ROE, and $386M shareholder returns highlight 2025 success.
Medicare Shift: Medicare Supplement NAP up 49% annually, driven by consumer preference and higher cross-sell potential.
ROE Target Progress: 2026 EPS guidance of $4.25-$4.45 reflects 8% growth, with 12% ROE target by 2027.
Investment Discipline: 12+ quarters of >6% new money yields, $31B high-quality portfolio, and cautious risk-taking in alternatives.
Macroeconomic Resilience: Agent productivity focus and demographic tailwinds offset economic headwinds.

Earnings

EPS

Revenue

Revenue & Expenses

Key Indicators

CNO Financial Group (CNO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

CNO Financial Group (CNO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

CNO Financial Group (CNO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

CNO Financial Group (CNO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown